BHVN News and Press, Biohaven Pharmaceutical Holding Company Ltd. From 04/19/24

2024-04-19 23:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-18 06:12:57 ET More on Biohaven Biohaven's Bounce Back: A Missed Call Turns Bullish (Rating Upgrade) Biohaven stock slides 15% amid data presentations RBC Capital starts Biohaven at outperform, cites epilepsy drug Read the full article on Seeking Al...

Biohaven Announces Pricing of $230 Million Public Offering of Common Shares PR Newswire NEW HAVEN, Conn. , April 18, 2024 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN), a biopharmaceutical company focused on the discovery, development, and commercialization of l...

2024-04-17 16:11:14 ET More on Biohaven Biohaven's Bounce Back: A Missed Call Turns Bullish (Rating Upgrade) Biohaven stock slides 15% amid data presentations RBC Capital starts Biohaven at outperform, cites epilepsy drug Seeking Alpha’s Quant Rating o...

2024-04-15 13:54:20 ET More on Biohaven Biohaven's Bounce Back: A Missed Call Turns Bullish (Rating Upgrade) RBC Capital starts Biohaven at outperform, cites epilepsy drug UBS starts Biohaven at buy, cites diverse pipeline Seeking Alpha’s Quant Rating ...

Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates PR Newswire Biohaven's first-in-class Molecular Degrader of Extracellular Proteins (MoDE™) techn...

2024-04-04 02:12:07 ET Summary Immunovant's IMVT-1402 shows promise for at-home autoimmune treatment, with a differentiated subcutaneous delivery. Phase 1 data indicate significant IgG reductions without major side effects, advancing toward registrational trials. Financial hea...

2024-03-31 02:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) is the focus of IBN's latest stock spotlight. The company's shares have moved -0.78% on the day to $57.6. Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and...

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) is the focus of IBN's latest stock spotlight. The company's shares have moved 12.93% on the day to $55.95. Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological an...